BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | - | - | - | - | - |
What is the latest Deferred Tax Assets / Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Deferred Tax Assets / Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Deferred Tax Assets / Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹303.4 Cr | 0.7% | -20.7% | 42.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| CIPLA | ₹108,412.0 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 0.7% |
-20.7% |
42.5% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses